<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01993277</url>
  </required_header>
  <id_info>
    <org_study_id>0001</org_study_id>
    <nct_id>NCT01993277</nct_id>
  </id_info>
  <brief_title>Evaluating Neuromodulation Technologies in Early Recovery</brief_title>
  <official_title>A Comparator Trial Evaluating Three Neuromodulation Technologies' Effectiveness in Early Recovery From Substance Abuse Disorders as Compared to Relaxation Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Behavioral Health of the Palm Beaches</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Behavioral Health of the Palm Beaches</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is an open-label comparative effectiveness clinical trial evaluating the impact of
      three neuromodulation treatment devices to improve the mental health and sobriety status of
      recovering substance abuse patients. We intend to enroll 200 patients to give us a sufficient
      number of subjects for the planned comparisons. Following informed consent and baseline
      assessment, patients will be randomly assigned to receive either 1) 15 40-minute sessions of
      Nexalin Brain Stimulator, a cranial electrical stimulation (CES) device, once-per-day within
      a 3-week time-frame; 2) 30 20-minute sessions of the Fischer Wallace Stimulator, another CES
      device, twice-per-day within a 3-week time-frame; 3) 15 40-minute sessions of the DAVID
      Delight, an audio-visual stimulation device (AVS), once-per-day within a 3-week time-frame;
      OR 4) the control-group condition of 15 40-minute relaxation therapy sessions once-per-day
      within a 3-week time-frame. All subjects will then be reassessed at the end of the 3 weeks of
      treatment and again 1, 3, and 6 months later. In addition to the assigned treatments, all
      patients will also receive the standard array of services that are provided by Behavioral
      Health of the Palm Beaches (BHOPB) including as clinically appropriate, psychiatric
      medication management and Eye Movement Desensitization Response (EMDR) therapy. Patients
      diagnosed with Post Traumatic Stress Disorder (PTSD) are assessed to determine their
      suitability for EMDR and if suitable, will receive 2 or more EMDR sessions. Patients without
      PTSD do not receive EMDR therapy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Quick Inventory of Depressive Symptomsâ€”Self-Report (QIDS-SR)</measure>
    <time_frame>Change in baseline depressive symtpoms, after 3 weeks of treatment, and 1, 3, and 6 months followup</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>State-Trait Anxiety Inventory (STAI)</measure>
    <time_frame>Change in baseline anxiety symtpoms, after 3 weeks of treatment, and 1, 3, and 6 months followup</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Pittsburgh Sleep Scale (PSS)</measure>
    <time_frame>Change in baseline insomnia symtpoms, after 3 weeks of treatment, and 1, 3, and 6 months followup</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>16-item Quality of Life Enjoyment and Satisfaction Questionnaire (QLES)</measure>
    <time_frame>Change in baseline quality of life, after 3 weeks of treatment, and 1, 3, and 6 months followup</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Brief Substance Craving Scale (BSCS)</measure>
    <time_frame>Change in baseline craving intensity after the 5th, 10th, and 15th treatment sessions</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Depression</condition>
  <condition>Anxiety</condition>
  <condition>Insomnia</condition>
  <arm_group>
    <arm_group_label>Fischer Wallace Stimulator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>30 20-minute sessions of the Fischer Wallace Stimulator administered twice-per-day within a 3-week time-frame;</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nexalin Brain Stimulator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>15 40-minute sessions of Nexalin Brain Stimulator adminsitered once-per-day within a 3-week time-frame</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DAVID Delight Stimulator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>15 40-minute sessions of the DAVID Delight administered once-per-day within a 3-week time-frame</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Relaxation Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>15 40-minute relaxation therapy sessions once-per-day within a 3-week time-frame</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nexalin Brain Stimulator</intervention_name>
    <arm_group_label>Nexalin Brain Stimulator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fischer Wallace Stimulator</intervention_name>
    <arm_group_label>Fischer Wallace Stimulator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>David Delight Stimulator</intervention_name>
    <arm_group_label>DAVID Delight Stimulator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Relaxation Therapy</intervention_name>
    <arm_group_label>Relaxation Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Adults between the ages of 18 and 75 in early recovery from a substance abuse disorder.

        Exclusion Criteria:

        The exclusion criteria are patients diagnosed with 1) an uncontrolled seizure disorder, 2)
        a psychotic disorder with currently active features (e.g., paranoia), 3) a dissociative
        identity disorder, 4) a manic episode within the past month, 5) patients with a pace-maker
        or implanted vagal nerve stimulator, patients prescribed Subocone, Subutext, &amp;/or any
        psychostimulant medication (e.g., Alderol, Concerta, Focalin, Metadate, Vyvance, etc.)
        since these medications interfere with the ability of these neuromodulation devices'
        ability to have the intended effect on patients, and 7) pregnant woman.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tammy Malloy, LCSW</last_name>
    <role>Principal Investigator</role>
    <affiliation>Behavioral Health of the Palm Beaches</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jodi Star, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Behavioral Health of the Palm Beaches</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kate Reynolds, MSW</last_name>
    <role>Principal Investigator</role>
    <affiliation>Behavioral Health of the Palm Beaches</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kate Reynolds, MSW</last_name>
    <phone>561-465-1263</phone>
    <email>kreynolds@bhpalmbeach.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Behavioral Health of the Palm Beaches</name>
      <address>
        <city>North Palm Beach</city>
        <state>Florida</state>
        <zip>33408</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kate Reynolds</last_name>
      <phone>561-465-1263</phone>
      <email>kreynolds@bhpalmbeach.com</email>
    </contact>
    <investigator>
      <last_name>Alan Stevens, MSW</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2013</study_first_submitted>
  <study_first_submitted_qc>November 20, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2013</study_first_posted>
  <last_update_submitted>December 16, 2014</last_update_submitted>
  <last_update_submitted_qc>December 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

